CAMP4 Therapeutics Statistics Share Statistics CAMP4 Therapeutics has 20.16M
shares outstanding. The number of shares has increased by 1121.26%
in one year.
Shares Outstanding 20.16M Shares Change (YoY) 1121.26% Shares Change (QoQ) 0% Owned by Institutions (%) 26.33% Shares Floating 2.64M Failed to Deliver (FTD) Shares 176 FTD / Avg. Volume 0.17%
Short Selling Information The latest short interest is 221.46K, so 1.1% of the outstanding
shares have been sold short.
Short Interest 221.46K Short % of Shares Out 1.1% Short % of Float 3.92% Short Ratio (days to cover) 2.13
Valuation Ratios The PE ratio is -1.97 and the forward
PE ratio is -0.76.
CAMP4 Therapeutics's PEG ratio is
-0.35.
PE Ratio -1.97 Forward PE -0.76 PS Ratio 156.16 Forward PS 36 PB Ratio 1.61 P/FCF Ratio -2.21 PEG Ratio -0.35
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for CAMP4 Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.92,
with a Debt / Equity ratio of 0.14.
Current Ratio 6.92 Quick Ratio 6.92 Debt / Equity 0.14 Debt / EBITDA -0.17 Debt / FCF -0.19 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $11.85K Profits Per Employee $-941.65K Employee Count 55 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is -0.59, so CAMP4 Therapeutics's
price volatility has been lower than the market average.
Beta -0.59 52-Week Price Change n/a 50-Day Moving Average 1.55 200-Day Moving Average 3.42 Relative Strength Index (RSI) 48.27 Average Volume (20 Days) 106,014
Income Statement In the last 12 months, CAMP4 Therapeutics had revenue of 652K
and earned -51.79M
in profits. Earnings per share was -2.66.
Revenue 652K Gross Profit 652K Operating Income -53.09M Net Income -51.79M EBITDA -51.39M EBIT -53.09M Earnings Per Share (EPS) -2.66
Full Income Statement Balance Sheet The company has 64.04M in cash and 8.65M in
debt, giving a net cash position of 55.39M.
Cash & Cash Equivalents 64.04M Total Debt 8.65M Net Cash 55.39M Retained Earnings -211.75M Total Assets 51.27M Working Capital 33.75M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -45.56M
and capital expenditures -441K, giving a free cash flow of -46M.
Operating Cash Flow -45.56M Capital Expenditures -441K Free Cash Flow -46M FCF Per Share -2.36
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -8142.33% and -7943.4%.
Gross Margin 100% Operating Margin -8142.33% Pretax Margin -7943.4% Profit Margin -7943.4% EBITDA Margin -7882.21% EBIT Margin -8142.33% FCF Margin -7055.67%
Dividends & Yields CAMP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for CAMP is $17.5,
which is 1074.5% higher than the current price. The consensus rating is "Buy".
Price Target $17.5 Price Target Difference 1074.5% Analyst Consensus Buy Analyst Count 5
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 25, 1996. It was a
forward
split with a ratio of 2:1.
Last Split Date Mar 25, 1996 Split Type forward Split Ratio 2:1
Scores Altman Z-Score -7.44 Piotroski F-Score 3
